Biopharma Vision LLC provides a broad range of business development oriented consulting serves to help our clients to identify their commercial needs and provide solutions in achieving corporate objectives:
Overall business and corporate planning
- business plan and corporate strategy
- product profiling and positioning
- IP management
Commercial assessment
- in-depth market research
- competition landscape analysis
- financial modeling and valuation
Corporate partnership
- assists clients in identifying appropriate global business partners
- establish channel of dialogue and coordinate business discussions
- advise clients on deal structures and valuations
- facilitate agreement execution
Global business opportunity match-making
- identify and drive strategic partnerships between US and Chinese biopharmaceutical companies
- represent client companies in promoting products and technologies
Selected sample projects successfully completed
2007
- conducted a comprehensive R&D pipeline and competition analysis in 5 disease indications defined by the client
- performed market research and financial assessment for a client's oncology compound under development; provided appropriate product development and pricing strategies
- negotiated and executed an international licensing and distribution agreement with a Japanese partner for a client 's primary cell based research product
- assessed European capital markets including Euronext and AIM for a potential fund raising/IPO event for a client
2008
- capital raising for a clinical diagnostic client in its Series B round
- generated Private Placement Memorandum and road show package;
- resulted in receiving 2 term sheets from investors with aggregated capital of $15M
- conducted market research to pressure test a new product concept proposed by a client
- performed 1st and 2nd market research to define the optimal product profile
- assessed and characterized reimbursement landscape, potential drug coverage, coding and pricing strategy
2009
- put together a Confidential Information Memorandum for a client’s ph II compound
- assisted in the due diligence process in the client’s partnering program
2010-2011
- conducted an extensive commercial assessment of 3 distinctive products in the areas of ENT (Ear, Nose & Throat), including technological feasibility, clinical needs, development risk & timeline, addressable market & commercial potential, regulatory strategy, pricing & reimbursement, financial projection & valuations